Found 67 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

18 years - 60 years
All genders
Phase 3
Interventional
This study investigates the effects of subcutaneous (under the skin) administration of an investigational medication compared to intravenous (through the vein) administration in adults with multiple sclerosis.The study evaluates how the investigational medication is tolerated and its effects on participants. It focuses on understanding the safety and effectiveness of the …
42 days - 89 days
Accepts healthy volunteer
All genders
Phase 3
The purpose of this study is to investigate a 21-valent pneumococcal conjugate vaccine in healthy infants. The study examines how infants' bodies respond to different lots of this investigational vaccine.This study evaluates the immune response and safety of the investigational vaccine compared to a licensed vaccine. It focuses on understanding …
12 years or above
Male
Phase 4
Interventional
This study investigates severe hemophilia by examining the effects of switching patients from one preventive treatment to another.The study evaluates the safety and tolerability of changing to an investigational medication after stopping the previous treatment.Who can participate: Male participants aged 12 years and older with severe hemophilia A who have …
18 years or above
All genders
Phase 2
Interventional
The purpose of this study is to investigate subcutaneous isatuximab in combination with carfilzomib and dexamethasone for people with relapsed and/or refractory multiple myeloma. This study focuses on adults who have previously received one to three lines of therapy.This study evaluates the overall response rate of the medication combination. It …
18 years or above
All genders
Phase 2
Interventional
This study investigates the effectiveness of different investigational medications compared to a placebo in improving lung capacity in participants with Interstitial Lung Disease (ILD) secondary to Systemic Sclerosis (SSc). The purpose is to observe changes from the start to the end of the treatment period at Week 52.Participants in the …
18 years - 45 years
All genders
Phase 1/2
Interventional
This study investigates a vaccine for mild acne. The purpose of this study is to evaluate how safe the vaccine is and how well it works for people with mild acne.Researchers will look at how the body responds to the vaccine. They will check if it is safe and see …
60 years or above
All genders
Phase 1/2
Interventional
This study investigates Geographic Atrophy secondary to Age-related Macular Degeneration. Participants will receive a one-time intravitreal injection of an investigational medication to evaluate its effects.The study focuses on evaluating the safety and efficacy of the investigational medication for treating Geographic Atrophy associated with Age-related Macular Degeneration.Who can participate: Participants must …
2 years - 17 years
All genders
Phase 3
Interventional
This study investigates the safety and ability of a new investigational pneumococcal vaccine to help the body make antibodies in children and adolescents with sickle cell disease.The study compares the investigational vaccine to a licensed pneumococcal vaccine. It evaluates whether the investigational vaccine is effective in producing an immune response.Who …
50 years or above
All genders
Phase 4
Interventional
This study investigates early polymyalgia rheumatica. The purpose is to evaluate the effects of an investigational medication compared to a placebo.This study evaluates the safety and tolerability of the investigational medication. It focuses on understanding how well the medication works in managing symptoms.Who can participate: Adults aged 50 years and …
18 years or above
All genders
Interventional
This study investigates the experience of adults with relapsed or refractory multiple myeloma. Participants will receive standard care with an investigational medication and provide data through various methods.The study evaluates the treatment experience by collecting data on quality of life, treatment adherence, and symptom burden. It uses a combination of …